Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease

Progress in Neurobiology

Volumn 96, Issue 1, 2012, Pages 87-95

  Salminen, Antero ^a,b   Kaarniranta, Kai ^a,b   Haapasalo, Annakaisa ^a,b   Hiltunen, Mikko ^a,b   Soininen, Hilkka ^a,b   Alafuzoff, Irina ^b,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Aging; Alzheimer; Autophagy; NF B; P62; Tau

Indexed keywords

ALPHA SYNUCLEIN; CASPASE 6; CASPASE 8; CYCLIC AMP; I KAPPA B; PROTEIN P62; TAU PROTEIN; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AUTOPHAGY; BINDING SITE; CELL FATE; CELL NUCLEUS; CELL SURVIVAL; CELLULAR IMMUNITY; CYTOPLASM; DEGENERATIVE DISEASE; DIMERIZATION; DNA DAMAGE; DNA METHYLATION; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; NEUROFIBRILLARY TANGLE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TAUOPATHY; UBIQUITINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALZHEIMER DISEASE; ANIMALS; HUMANS; SIGNAL TRANSDUCTION; TAU PROTEINS; UBIQUITIN;

EID: 83155185539     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2011.11.005     Document Type: Review

References (112)

1. Babu J.R., Geetha T., Wooten M.W. Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation. J. Neurochem. 2005, 94:192-203.
2. Babu J.R., Seibenhener M.L., Peng J., Strom A.L., Kemppainen R., Cox N., Zhu H., Wooten M.C., Diaz-Meco M.T., Moscat J., Wooten M.W. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J. Neurochem. 2008, 106:107-120.
3. Belizario J.E., Alves J., Garay-Malpartida M., Occhiucci J.M. Coupling caspase cleavage and proteasomal degradation of proteins carrying PEST motif. Curr. Protein Pept. Sci. 2008, 9:210-220.
4. Benito E., Barco A. CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models. Trends Neurosci. 2010, 33:230-240.
5. Bjorkoy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., Stenmark H., Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 2005, 171:603-614.
6. Bonda D.J., Lee H., Kudo W., Zhu X., Smith M.A., Lee H. Pathological implications of cell cycle re-entry in Alzheimer's disease. Expert Rev. Mol. Med. 2010, 12:e19.
7. Boonen R.A., van Tijn P., Zivkovic D. Wnt signaling in Alzheimer's disease: up or down, that is the question. Ageing Res. Rev. 2009, 8:71-82.
8. Braak H., Thal D.R., Tredici K.D. Nerve cells immunoreactive for p62 in select hypothalamic and brainstem nuclei of controls and Parkinson's disease cases. J. Neural Transm. 2011, 118:809-819.
9. Burns M.P., Zhang L., Rebeck G.W., Querfurth H.W., Moussa C.E.H. Parkin promotes intracellular Aβ1-42 clearance. Hum. Mol. Genet. 2009, 18:3206-3216.
10. Chouliaras L., Rutten B.P.F., Kenis G., Peerbooms O., Visser P.J., Verhey F., van Os J., Steinbusch H.W.M., van den Hove D.L.A. Epigenetic regulation in the pathophysiology of Alzheimer's disease. Prog. Neurobiol. 2010, 90:498-510.
11. Christian F., Anthony D.F., Vadrevu S., Riddell T., Day J.P., McLeod R., Adams D.R., Baillie G.S., Houslay M.D. p62(SQSTM1) and cyclic AMP phosphodiesterase-4A4 (PDE4A4) locate to a novel, reversible protein aggregate with links to autophagy and proteasome degradation pathways. Cell. Signal. 2010, 22:1576-1596.
12. Coulson E.J., May L.M., Sykes A.M., Hamlin A.S. The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer's disease. Neuroscientist 2009, 15:317-323.
13. C receptors, PKC-ζ and Kvβ2. J. Biol. Chem. 2003, 278:6128-6135.
14. Day J.P., Lindsay B., Riddell T., Jiang Z., Allcock R.W., Abraham A., Sookup S., Christian F., Bogum J., Martin E.K., Rae R.L., Anthony D., Rosair G.M., Houslay D.M., Huston E., Baillie G.S., Klussmann E., Houslay M.D., Adams D.R. Elucidation of a structural basis for the inhibitor-driven, p62 (SQSTM1)-dependent intracellular redistribution of cAMP phosphodiesterase-4A4 (PDE4A4). J. Med. Chem. 2011, 10.1021/jm200070e.
15. De la Monte S.M. Insulin resistance and Alzheimer's disease. BMB Rep. 2009, 42:475-481.
16. De Strooper B. Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol. Rev. 2010, 90:465-494.
17. Douglas P.M., Dillin A. Protein homeostasis and aging in neurodegeneration. J. Cell Biol. 2010, 190:719-729.
18. Du H., Guo L., Yan S., Sosunov A.A., McKhann G.M., Yan S.S. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:18670-18675.
19. Du Y., Wooten M.C., Gearing M., Wooten M.W. Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease. Free Radic. Biol. Med. 2009, 46:492-501.
20. Du Y., Wooten M.C., Wooten M.W. Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease. Neurobiol. Dis. 2009, 35:302-310.
21. Feng Y., Longmore G.D. The LIM protein Ajuba influences interleukin-1-induced NF-κB activation by affecting the assembly and activity of the protein kinase Cζ/p62/TRAF6 signaling complex. Mol. Cell. Biol. 2005, 25:4010-4022.
22. Ferrer I. Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease. J. Bioenerg. Biomembr. 2009, 41:425-431.
23. Festjens N., vanden Berghe T., Cornelis S., Vandenabeele P. RIP1, a kinase on crossroads of a cell's decision to live or die. Cell Death Differ. 2007, 14:400-410.
24. Frisardi V., Solfrizzi V., Capurso C., Imbimbo B.P., Vendemiale G., Seripa D., Pilotto A., Panza F. Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?. J. Alzheimers Dis. 2010, 21:57-63.
25. Gal J., Ström A.L., Kilty R., Zhang F., Zhu H. p62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis. J. Biol. Chem. 2007, 282:11068-11077.
26. Gao C., Cao W., Bao L., Zuo W., Xie G., Cai T., Fu W., Zhang J., Wu W., Zhang X., Chen Y.G. Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation. Nat. Cell Biol. 2010, 12:781-790.
27. Geetha T., Wooten M.W. Structure and functional properties of the ubiquitin binding protein p62. FEBS Lett. 2002, 512:19-24.
28. Geetha T., Wooten M.W. Association of the atypical protein kinase C-interacting protein p62/ZIP with nerve growth factor receptor TrkA regulates receptor trafficking and Erk5 signaling. J. Biol. Chem. 2003, 278:4730-4739.
29. Geetha T., Jiang J., Wooten M.W. Lysine 63 polyubiquitination of the nerve growth factor receptor TrkA directs internalization and signaling. Mol. Cell 2005, 20:301-312.
30. Geetha T., Seibenhener M.L., Chen L., Madura K., Wooten M.W. p62 serves as a shuttling factor for TrkA interaction with the proteasome. Biochem. Biophys. Res. Commun. 2008, 374:33-37.
31. Geisler S., Holmström K.M., Skujat D., Fiesel F.C., Rothfuss O.C., Kahle P.J., Springer W. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 2010, 12:119-131.
32. Gong J., Xu J., Bezanilla M., van Huizen R., Derin R., Li M. Differential stimulation of PKC phosphorylation of potassium channels by ZIP1 and ZIP2. Science 1999, 285:1565-1569.
33. Hocking L.J., Lucas G.J., Daroszewska A., Mangion J., Olavesen M., Cundy T., Nicholson G.C., Ward L., Bennett S.T., Wuyts W., van Hul W., Ralston S.H. Domain-specific mutations in sequestome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum. Mol. Genet. 2002, 11:2735-2739.
34. Ichimura Y., Kumanomidou T., Sou Y., Mizushima T., Ezaki J., Ueno T., Kominami E., Yamane T., Tanaka K., Komatsu M. Structural basis for sorting mechanism of p62 in selective autophagy. J. Biol. Chem. 2008, 283:22847-22857.
35. Inami Y., Waguri S., Sakamoto A., Kouno T., Nakada K., Hino O., Watanabe S., Ando J., Iwadate M., Yamamoto M., Lee M.S., Tanaka K., Komatsu M. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J. Cell Biol. 2011, 193:275-284.
36. Inestrosa N.C., Arenas E. Emerging roles of Wnts in the adult nervous system. Nat. Rev. Neurosci. 2010, 11:77-86.
37. Into T., Inomata M., Niida S., Murakami Y., Shibata K. Regulation of MyD88 aggregation and the MyD88-dependent signaling pathway by sequestosome 1 and histone deacetylase 6. J. Biol. Chem. 2010, 285:35759-35769.
38. Iqbal K., Grundke-Iqbal I. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. J. Cell. Mol. Med. 2008, 12:38-55.
39. Jain A., Lamark T., Sjottem E., Larsen K.B., Awuh J.A., Overvatn A., McMahon M., Hayes J.D., Johansen T. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J. Biol. Chem. 2010, 285:22576-22591.
40. Jiang J., Parameshwaran K., Seibenhener M.L., Kang M.G., Suppiramaniam V., Huganir R.L., Diaz-Meco M.T., Wooten M.W. AMPA receptor trafficking and synaptic plasticity require SQSTM1/p62. Hippocampus 2009, 19:392-406.
41. Johansen T., Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011, 7:279-296.
42. lck SH2 domain. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:5991-5995.
43. Kaltschmidt B., Kaltschmidt C. NF-κB in the nervous system. Cold Spring Harb. Perspect. Biol. 2009, 1:a001271.
44. Kanninen K., Heikkinen R., Malm T., Rolova T., Kuhmonen S., Leinonen H., Ylä-Herttuala S., Tanila H., Levonen A.-L., Koistinaho M., Koistinaho J. Intrahippocampal injection of lentiviral vector expressing Nrf2 improves spatial learning in mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:16505-16510.
45. Khandelwal P.J., Herman A.M., Hoe H.S., Rebeck G.W., Moussa C.E.H. Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated Aβ in AD models. Hum. Mol. Genet. 2011, 20:2091-2102.
46. Kim Y., Park M.K., Uhm D.Y., Shin J., Chung S. Modulation of delayed rectifier potassium channels by α1-adrenergic activation via protein kinase Cζ and p62 in PC12 cells. Neurosci. Lett. 2005, 387:43-48.
47. Ko H.S., Uehara T., Tsuruma K., Nomura Y. Ubiquilin interacts with ubiquitylated proteins and proteasome through its ubiquitin-associated and ubiquitin-like domains. FEBS Lett. 2004, 566:110-114.
48. Komatsu M., Kurokawa H., Waguri S., Taguchi K., Kobayashi A., Ichimura Y., Sou Y.S., Ueno I., Sakamoto A., Tong K.I., Kim M., Nishito Y., Iemura S., Natsume T., Ueno T., Kominami E., Motohashi H., Tanaka K., Yamamoto M. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 2010, 12:213-223.
49. Komatsu M., Waguri S., Koike M., Sou Y.S., Ueno T., Hara T., Mizushima N., Iwata J., Ezaki J., Murata S., Hamazaki J., Nishito Y., Iemura S., Natsume T., Yanagawa T., Uwayama J., Warabi E., Yoshida H., Ishii T., Kobayashi A., Yamamoto M., Yue Z., Uchiyama Y., Kominami E., Tanaka K. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007, 131:1149-1163.
50. Kuusisto E., Kauppinen T., Alafuzoff I. Use of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol. Appl. Neurobiol. 2008, 34:169-180.
51. Kuusisto E., Salminen A., Alafuzoff I. Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. Neuroreport 2001, 12:2085-2090.
52. Kuusisto E., Suuronen T., Salminen A. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochim. Biophys. Res. Commun. 2001, 280:223-228.
53. Kuusisto E., Salminen A., Alafuzoff I. Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation. Neuropathol. Appl. Neurobiol. 2002, 28:228-237.
54. Lamark T., Kirkin V., Dikic I., Johansen T. NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle 2009, 8:1986-1990.
55. Lamark T., Perander M., Outzen H., Kristiansen K., Overvatn A., Michaelsen E., Bjorkoy G., Johansen T. Interaction codes within the family of mammalian Phox and Bem1p domain-containing proteins. J. Biol. Chem. 2003, 278:34568-34581.
56. Lau A., Wang X.J., Zhao F., Villeneuve N.F., Wu T., Jiang T., Sun Z., White E., Zhang D.D. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol. Cell. Biol. 2010, 30:3275-3285.
57. Lee J.Y., Nagano Y., Taylor J.P., Lim K.L., Yao T.P. Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J. Cell Biol. 2010, 189:671-679.
58. Long J., Gallagher T.R.A., Cavey J.R., Sheppard P.W., Ralston S.H., Layfield R., Searle M.S. Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformation switch. J. Biol. Chem. 2008, 283:5427-5440.
59. Lovell M.A., Gabbita S.P., Markesbery W.R. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J. Neurochem. 1999, 72:771-776.
60. Mastroeni D., Grover A., Delvaux E., Whiteside C., Coleman P.D., Rogers J. Epigenetic mechanisms in Alzheimer's disease. Neurobiol. Aging 2011, 10.1016/j.neurobiolaging.2010.08.017.
61. Mathew R., Karp C.M., Beaudoin B., Vuong N., Chen G., Chen H.Y., Bray K., Reddy A., Bhanot G., Gelinas C., DiPaola R.S., Karantza-Wadsworth V., White E. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009, 137:1062-1075.
62. Mehan S., Meena H., Sharma D., Sankhla R. JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities. J. Mol. Neurosci. 2011, 43:376-390.
63. Moreira P.I., Carvalho C., Zhu X., Smith M.A., Perry G. Mitochondrial dysfunction is a trigger of Alzheimer's disease Pathophysiology. Biochim. Biophys. Acta 2010, 1802:2-10.
64. Moreira P.I., Siedlak S.L., Wang X., Santos M.S., Oliveira C.R., Tabaton M., Nunomura A., Szweda L.I., Aliev G., Smith M.A., Zhu X., Perry G. Autophagocytosis of mitochondria is prominent in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 2007, 66:525-532.
65. Moscat J., Diaz-Meco M.T., Wooten M.W. Signal integration and diversification through the p62 scaffold protein. Trends Biochem. Sci. 2006, 32:95-100.
66. Moscat J., Diaz-Meco M.T., Albert A., Campuzano S. Cell signaling and function organized by PB1 domain interactions. Mol. Cell 2006, 23:631-640.
67. Moscat J., Diaz-Meco M.T., Wooten M.w. Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complex. Cell Death Differ. 2009, 16:1426-1437.
68. Nakamura K., Kimple A.J., Siderovski D.P., Johnson G.L. PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-κB activation. J. Biol. Chem. 2010, 285:2077-2089.
69. Nixon R.A., Wegiel J., Kumar A., Yu W.H., Peterhoff C., Cataldo A., Cuervo A.M. Extensive involvement of autophagy in Alzheimer's disease: an immune-electron microscopy study. J. Neuropathol. Exp. Neurol. 2005, 64:113-122.
70. Nixon R.A., Yang D.S. Autophagy failure in Alzheimer's disease - locating the primary defect. Neurobiol. Dis. 2011, 10.1016/j.nbd.2011.01.021.
71. Nezis I.P., Simonsen A., Sagona A.P., Finley K., Gaumer S., Contamine D., Rusten T.E., Stenmark H., Brech A. Ref(2)P, the Drosophila melanogaster homologue of mammalian p62, is required for the formation of protein aggregates in adult brain. J. Cell Biol. 2008, 180:1065-1071.
72. Noda Y., Kohjima M., Izaki T., Ota K., Yoshinaga S., Inagaki F., Ito T., Sumimoto H. Molecular recognition in dimerization between PB1 domains. J. Biol. Chem. 2003, 278:43516-43524.
73. Norman J.M., Cohen G.M., Bampton E.T. The in vivo cleavage of the hAtg proteins by cell death proteases. Autophagy 2010, 6:1042-1056.
74. Okatsu K., Saisho K., Shimanuki M., Nakada K., Shitara H., Sou Y., Kimura M., Sato S., Hattori N., Komatsu M., Tanaka K., Matsuda N. p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria. Genes Cell 2010, 15:887-900.
75. Paine M.G., Babu J.R., Seibenhener M.L., Wooten M.W. Evidence for p62 aggregate formation: role in cell survival. FEBS Lett. 2005, 579:5029-5034.
76. Pankiv S., Clausen T.H., Lamark T., Brech A., Bruun J.A., Outzen H., Overvatn A., Bjorkoy G., Johansen T. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 2007, 282:24131-24145.
77. Pankiv S., Lamark T., Bruun J.A., Overvatn A., Bjorkoy G., Johansen T. Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies. J. Biol. Chem. 2010, 285:5941-5953.
78. lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:12338-12342.
79. Pastorcic M., Das H.K. Ets transcription factors ER81 and Elk1 regulate the transcription of the human presenilin 1 gene promoter. Mol. Brain Res. 2003, 113:57-66.
80. Petrucelli L., Dickson D., Kehoe K., Taylor J., Snyder H., Grover A., De Lucia M., McGowan E., Lewis J., Prihar G., Kim J., Dillmann W.H., Browne S.E., Hall A., Voellmy R., Tsuboi Y., Dawson T.M., Wolozin B., Hardy J., Hutton M. CHIP and Hsp90 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet. 2004, 13:703-714.
81. Pikkarainen M., Hartikainen P., Alafuzoff I. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry. J. Neuropathol. Exp. Neurol. 2008, 67:280-298.
82. Pikkarainen M., Hartikainen P., Soininen H., Alafuzoff I. Distribution and pattern of pathology in subjects with familial or sporadic late-onset cerebellar ataxia as assessed by p62/sequestosome immunohistochemistry. Cerebellum 2011, 10.1007/s12311-011-0281-2.
83. Pursiheimo J.-P., Rantanen K., Heikkinen P.T., Johansen T., Jaakkola P.M. Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62. Oncogene 2009, 28:334-344.
84. Rechsteiner M., Rogers S.W. PEST sequences and regulation of proteolysis. Trends Biochem. Sci. 1996, 21:267-271.
85. Rodriguez A., Duran A., Selloum M., Champy M.F., Diez-Guerra F.J., Flores J.M., Serrano M., Auwerx J., Diaz-Meco M.T., Moscat J. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab. 2006, 3:211-222.
86. Roodman G.D. Insights into the pathogenesis of Paget's disease. Ann. N.Y. Acad. Sci. 2010, 1192:176-180.
87. Rosen K.M., Moussa C.E.H., Lee H.K., Kumar P., Kitada T., Qin G., Fu Q., Querfurth H.W. Parkin reverses intracellular β-amyloid accumulation and its negative effects on proteasome function. J. Neurosci. Res. 2010, 88:167-178.
88. Sahara N., Murayama M., Mizoroki T., Urushitani M., Imai Y., Takahashi R., Murata S., Tanaka K., Takashima A. In vivo evidence of CHIP up-regulation attenuating tau aggregation. J. Neurochem. 2005, 94:1254-1263.
89. Sakamoto K., Karelina K., Obrietan K. CREB: a multifaceted regulator of neuronal plasticity and protection. J. Neurochem. 2011, 116:1-9.
90. Salminen A., Ojala J., Kaarniranta K., Hiltunen M., Soininen H. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease. Prog. Neurobiol. 2011, 93:99-110.
91. Sanz L., Diaz-Meco M.T., Nakano H., Moscat J. The atypical PKC-interacting protein p62 channels NF-κB activation by the IL-1-TRAF6 pathway. EMBO J. 2000, 19:1576-1586.
92. Sanz L., Sanchez P., Lallena M.J., Diaz-Meco M.T., Moscat J. The interaction of p62 with RIP links the atypical PKCs to NF-κB activation. EMBO J. 1999, 18:3044-3053.
93. Seibenhener M.L., Babu J.R., Geetha T., Wong H.C., Krishna N.R., Wooten M.W. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol. Cell. Biol. 2004, 24:8055-8068.
94. Shimura H., Schwartz D., Gygi S.P., Kosik K.S. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem. 2004, 279:4869-4876.
95. Shin J. p62 and the sequestosome, a novel mechanism for protein metabolism. Arch. Pharm. Res. 1998, 21:629-633.
96. Stumptner C., Heid H., Fuchsbichler A., Hauser H., Mischinger H.J., Zatloukal K., Denk H. Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent. Am. J. Pathol. 1999, 154:1701-1710.
97. Swerdlow R.H., Burns J.M., Khan S.M. The Alzheimer's disease mitochondrial cascade hypothesis. J. Alzheimers Dis. 2010, 20(Suppl. 2):S265-S279.
98. Takamura A., Komatsu M., Hara T., Sakamoto A., Kishi C., Waguri S., Eishi Y., Hino O., Tanaka K., Mizushima N. Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 2011, 25:795-800.
99. Terni B., Rey M.J., Boluda S., Torrejon-Escribano B., Sabate M.P., Calopa M., van Leeuwen F.W., Ferrer I. Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer's disease. Acta Neuropathol. 2007, 113:403-416.
100. lck, belongs to a new class of ubiquitin-binding proteins. J. Biol. Chem. 1996, 271:20235-20237.
101. Vadlamudi R.K., Shin J. Genomic structure and promoter analysis of the p62 gene coding a non-proteasomal multiubiquitin chain binding protein. FEBS Lett. 1998, 435:138-142.
102. Wang Y., Martinez-Vicente M., Kruger U., Kaushik S., Wong E., Mandelkow E.M., Cuervo A.M., Mandelkow E. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum. Mol. Genet. 2009, 18:4153-4170.
103. Waters S., Marchbank K., Solomon E., Whitehouse C., Gautel M. Interaction with LC3 and polyubiquitin chains link nbr1 to autophagic protein turnover. FEBS Lett. 2009, 583:1846-1852.
104. Whitworth A.J., Pallanck L.J. The PINK1/Parkin pathway: a mitochondrial quality control system?. J. Bioenerg. Biomembr. 2009, 41:499-503.
105. Wilson M.I., Gill D.J., Perisic O., Quinn M.T., Williams R.L. PB1 domain-mediated heterodimerization in NADPH oxidase and signaling complexes of atypical protein kinase C with Par6 and p62. Mol. Cell 2003, 12:39-50.
106. Wooten M.W., Geetha T., Seibenhener M.L., Babu J.R., Diaz-Meco M.T., Moscat J. The p62 scaffold regulates nerve growth-induced NF-κB activation by influencing TRAF6 polyubiquitination. J. Biol. Chem. 2005, 280:35625-35629.
107. Wooten M.W., Seibenhener M.L., Mamidipudi V., Diaz-Meco M.T., Barker P.A., Moscat J. The atypical protein kinase C-interacting protein p62 is a scaffold for NF-κB activation by nerve growth factor. J. Biol. Chem. 2001, 276:7709-7712.
108. Wu S., Mikhailov A., Kallo-Hosein H., Hara K., Yonezawa K., Avruch J. Characterization of ubiquilin 1, an mTOR-interacting protein. Biochim. Biophys. Acta 2002, 1542:41-56.
109. Xie J., Guo Q. PAR-4 is involved in regulation of β-secretase cleavage of the Alzheimer amyloid precursor protein. J. Biol. Chem. 2005, 280:13824-13832.
110. Yu H.B., Kielczewska A., Rozek A., Takenaka S., Li Y., Thorson L., Hancock R.E.W., Guarna M.M., North J.R., Foster L.J., Donini O., Finlay B.B. Sequestosome-1/p62 is the key intracellular target of innate defence regulator peptide. J. Biol. Chem. 2009, 284:36007-36011.
111. Zatloukal K., Stumptner C., Fuchsbichler A., Heid H., Schnoelzer M., Kenner L., Kleinert R., Prinz M., Aguzzi A., Denk H. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am. J. Pathol. 2002, 160:255-263.
112. Zhu X., Lee H.G., Raina A.K., Perry G., Smith M.A. The role of mitogen-activated protein kinase pathways in Alzheimer's disease. Neurosignals 2002, 11:270-281.